January 9, 2024 – A&M Capital Europe (“AMCE”), a London-based middle-market private equity investment firm with €650 million of assets under management, announces the acquisition of a majority stake in GBUK Group (the “Company”), a leading global provider of specialist single-use medical devices, from H2 Equity Partners (“H2EP”).
Headquartered in the United Kingdom, GBUK designs, develops and distributes a comprehensive portfolio of own and third-party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment. The Company is a top 20 supplier to the UK National Health Service (“NHS”) and supports healthcare professionals and patients in over 45 countries with more than 600,000 medical devices daily. GBUK has demonstrated a track record of penetrating new care areas by leveraging its R&D capabilities and a high-touch sales model hinging on wrap-around services.
The partnership with AMCE is expected to enable GBUK to enhance patient care further and drive the innovation required to support the evolving needs of patients and healthcare providers. Leveraging GBUK’s intimate understanding of patient needs, new product development expertise and global supply-chain capabilities, the Company is well-positioned to continue delivering on this mission and support patients globally.
Additionally, with AMCE’s support, GBUK intends to pursue bolt-on acquisitions, focusing primarily on proprietary medical device specialists in the United Kingdom and broader European and North American markets.
GBUK will continue under the leadership of its existing management team, led by CEO Mike Geering, with Mike and his team investing alongside AMCE. AMCE was advised by Weil, Gotshal & Manges as legal adviser, Houlihan Lokey as financial adviser, MDW Capital Partners as debt adviser, Boston Consulting Group as commercial adviser, Alvarez & Marsal as accounting and operational adviser, and EY as tax adviser.
About A&M Capital Partners
AMCE is a London-headquartered, middle-market private equity investment firm specialising in building pan-European platform companies through buy-and-build in the middle market. AMCE Fund I currently has €650 million of assets under management, and GBUK represents AMCE’s seventeenth transaction. More broadly, AMCE is part of A&M Capital, a multi-strategy private equity investment firm with ~€4.8 billion in assets under management across four investment strategies. In addition, A&M Capital maintains a strategic association with Alvarez & Marsal, one of the world’s largest operationally focused advisory firms. For additional information, please visit A&M Capital Europe’s website at www.a-mcapital.com.
